Luna Innovations Inc Receivables Turnover Ratio (LUNA), from the third quarter 2023 to the third quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Luna Innovations Inc  (NASDAQ: LUNA)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Luna Innovations Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Luna Innovations Inc's ability to collect accounts receivable sequentially worsen to 3.35, indicating more challenging environment then in the second quarter 2023, but still, it is a far cry from any concerns. Luna Innovations Inc's Accounts Receivable average collection period in the Sep 30 2023 quarter, has increased to 109 days, from 103 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 143 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1487, from overall ranking in the second quarter 2023 at 3262.

What is Receivable Turnover Ratio?
What is Luna Innovations Inc Selling?


What is Receivable Turnover Ratio?





LUNA Receivables Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Receivable Change 34.17 % 11.15 % 21.56 % 61.32 % 49.79 %
Y / Y Revenue Change 5.06 % 10.33 % 11.41 % 144.83 % 43.41 %
Receivable Turnover Ratio (TTM) 3.35 3.56 3.58 3.66 3.4
LUNA's Total Ranking # 1487 # 3262 # 3269 # 1475 #
Accounts Receivable average collection period days 109 102 102 100 107
Seq. Receivable Change 16.24 % 5.92 % -5.37 % 15.16 % -3.7 %
Seq. Revenue Change 6.11 % 15.25 % -21 % 8.74 % 11.43 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 5
Healthcare Sector # 144
Overall Market # 1487

Receivable Turnover Ratio Statistics
High Average Low
1.09 0.83 0.6
(Mar 31 2017)   (Jun 30 2022)






Financial Statements
Luna Innovations Inc's Accounts Receivable $ 39 Millions Visit LUNA's Balance sheet
Luna Innovations Inc's Sales TTM $ 116 Millions Visit LUNA's Income Statement
Sources of LUNA's Revenues Visit LUNA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LUNA's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
LUNA's Growth Rates LUNA's Roa LUNA's Inventory Turnover Ratio LUNA's Dividend Comparisons
LUNA's Profitability Ratios LUNA's Roi LUNA's Asset Turnover Ratio LUNA's Dividend Growth
LUNA's Valuation Ratios LUNA's Roe LUNA's Financial Strength Ratios LUNA's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Becton Dickinson And Company  8.11 $ 19,372.000  Millions$ 2,388.000  Millions
Acadia Pharmaceuticals Inc   8.10 $ 631.886  Millions$ 78.005  Millions
Beone Medicines Ltd   8.08 $ 2,204.465  Millions$ 272.789  Millions
Atricure Inc   8.08 $ 380.309  Millions$ 47.061  Millions
Cerus Corporation  8.07 $ 214.720  Millions$ 26.597  Millions
Cadre Holdings inc   8.05 $ 480.743  Millions$ 59.721  Millions
Ensign Group Inc  8.04 $ 3,558.509  Millions$ 442.690  Millions
Veracyte Inc   8.02 $ 343.149  Millions$ 42.793  Millions
Nephros Inc   7.99 $ 12.528  Millions$ 1.567  Millions
Vapotherm Inc   7.98 $ 67.598  Millions$ 8.466  Millions
Aveanna Healthcare Holdings Inc   7.98 $ 1,867.515  Millions$ 234.042  Millions
Insulet Corporation  7.98 $ 1,557.000  Millions$ 195.200  Millions
Glaukos Corp  7.95 $ 303.063  Millions$ 38.126  Millions
Moderna Inc   7.94 $ 9,121.000  Millions$ 1,149.000  Millions
Dynatronics Corporation  7.87 $ 36.828  Millions$ 4.680  Millions
Encompass Health Corporation  7.83 $ 4,149.400  Millions$ 529.875  Millions
Cardiff Oncology Inc   7.80 $ 3.521  Millions$ 0.452  Millions
Clearside Biomedical Inc   7.78 $ 2.211  Millions$ 0.284  Millions
Akebia Therapeutics Inc   7.73 $ 193.611  Millions$ 25.057  Millions
Avinger Inc   7.67 $ 7.318  Millions$ 0.954  Millions
Singular Genomics Systems Inc   7.64 $ 2.595  Millions$ 0.340  Millions
Shockwave Medical Inc   7.64 $ 670.271  Millions$ 87.764  Millions
Exelixis Inc   7.64 $ 1,774.473  Millions$ 232.410  Millions
Strata Skin Sciences Inc  7.59 $ 33.441  Millions$ 4.403  Millions
Inari Medical Inc   7.59 $ 468.832  Millions$ 61.763  Millions
Lemaitre Vascular Inc   7.57 $ 184.930  Millions$ 24.423  Millions
Encision Inc   7.56 $ 6.970  Millions$ 0.922  Millions
Alpha Teknova Inc   7.55 $ 35.550  Millions$ 4.709  Millions
Star Equity Holdings Inc   7.55 $ 77.173  Millions$ 10.224  Millions
Fate Therapeutics Inc   7.54 $ 106.213  Millions$ 14.088  Millions

Date modified: 2026-09-08T15:11:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.